The Health Care Burden of Hepatic Encephalopathy

Clin Liver Dis. 2020 May;24(2):263-275. doi: 10.1016/j.cld.2020.01.006. Epub 2020 Mar 2.

Abstract

Hepatic encephalopathy is a major neuropsychiatric complication of liver disease that affects 30% to 40% of cirrhotic patients. Hepatic encephalopathy is characterized by a brain dysfunction that is associated with neurologic complications. Those complications are associated with cognitive impairments, which negatively impacts patients' physical and mental health. In turn, hepatic encephalopathy poses a substantial economic and use burdens to the health care system. This article reviews the multidimensional aspects of the health care burden posed by hepatic encephalopathy.

Keywords: Economic burden; Health care costs; Health care resource use; Hepatic encephalopathy.

Publication types

  • Review

MeSH terms

  • Cost of Illness*
  • Emergency Service, Hospital / economics
  • Emergency Service, Hospital / statistics & numerical data
  • Gastrointestinal Agents / therapeutic use
  • Health Care Costs / statistics & numerical data*
  • Hepatic Encephalopathy / drug therapy
  • Hepatic Encephalopathy / economics*
  • Hospitalization / economics*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Lactulose / therapeutic use
  • Length of Stay / statistics & numerical data
  • Patient Admission / statistics & numerical data
  • Patient Readmission / economics
  • Patient Readmission / statistics & numerical data
  • Quality of Life*
  • Rifaximin / therapeutic use

Substances

  • Gastrointestinal Agents
  • Lactulose
  • Rifaximin